4502:TYO
Takeda Pharmaceutical Company
6 973,00 ¥
arrow_upward
+0,33%(+23,00) 1 d.
20. nov., 15:30:00 GMT+9 · JPY
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4502…
Atvērt
6 850 ¥
Augsta
7 016 ¥
Zema
6 846 ¥
Tirgus kapitalizācija
11,17 trilj.
Vid. apjoms
4,81 milj.
Apjoms
7,67 milj.
Dividende
2,90%
Ceturkšņa dividendes
51 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2027. gada 30. marts
Cenas/peļņas attiecība
333,00
Augstākā 52 ned.
7 037 ¥
Zemākā 52 ned.
4 384 ¥
Peļņa uz vienu akciju
21 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Atvērt
6 850 ¥
Augsta
7 016 ¥
Zema
6 846 ¥
Tirgus kapitalizācija
11,17 trilj.
Vid. apjoms
4,81 milj.
Apjoms
7,67 milj.
Dividende
2,90%
Ceturkšņa dividendes
51 ¥
Datums, kad tiek pārtraukta dividenžu izmaksa
2027. gada 30. marts
Cenas/peļņas attiecība
333,00
Augstākā 52 ned.
7 037 ¥
Zemākā 52 ned.
4 384 ¥
Peļņa uz vienu akciju
21 ¥
Apgrozībā esošās akcijas
784,48 milj.
Darbinieku skaits
47 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
WSJ
·
pirms 1 dienas
Dow, S&P 500 Poised to Close at a Correction
Yahoo Finance
·
pirms 6 stundām
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
24/7 Wall St.
·
pirms 9 stundām
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026
Beinsure
·
pirms 13 stundām
Dow Jones today: What’s next for stocks in 2027 after an 8% weekly crash?
Profils
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the largest pharmaceutical company in Japan, third largest such company in Asia behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Par “Takeda Pharmaceutical Company”
ĢenerāldirektorsChristophe Weber | Christophe Weber
Darbinieki47 tūkst.
Dibināšanas datums1781. gada 12. jūn.
Galvenais birojs-
SektorsHealth Care
Nozare-
Tīmekļa vietnetakeda.com